Sep 2026
Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.
Mariana T. Mendez, Tapojyoti Sanyal, Murali K. Mamidi et al.
· Leukemia · 0 citations